To further confirm IL-1β signaling, we tested the ability of B cells to activate IL-1β-dependent NFκB signaling in tumor cells by assessing phosphorylation of serine 536 of the p65 (RELA) subunit. This evidence concerns the gene NFKB1 and neoplasm.